 | • レポートコード：MRC2-11QY04743 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳卒中診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（虚血性脳卒中、出血性脳卒中）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳卒中診断・治療の競争状況、市場シェア ・世界の脳卒中診断・治療市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の脳卒中診断・治療市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の脳卒中診断・治療市場：用途別市場規模 2015年-2020年（虚血性脳卒中、出血性脳卒中） ・世界の脳卒中診断・治療市場：用途別市場規模予測 2021年-2026年（虚血性脳卒中、出血性脳卒中） ・北米の脳卒中診断・治療市場分析：米国、カナダ ・ヨーロッパの脳卒中診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳卒中診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳卒中診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳卒中診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced.
Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed in the global stroke diagnostics and therapeutics market.
Market Analysis and Insights: Global Stroke Diagnostics and Therapeutics Market
The global Stroke Diagnostics and Therapeutics market size is projected to reach US$ 23520 million by 2026, from US$ 22350 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Stroke Diagnostics and Therapeutics Scope and Market Size
Stroke Diagnostics and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stroke Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Market segment by Type, the product can be split into
Diagnostics
Therapeutics
Market segment by Application, split into
Ischemic Stroke
Haemorrhagic Stroke
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Stroke Diagnostics and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Stroke Diagnostics and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostics
1.4.3 Therapeutics
1.5 Market by Application
1.5.1 Global Stroke Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Ischemic Stroke
1.5.3 Haemorrhagic Stroke
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Stroke Diagnostics and Therapeutics Market Perspective (2015-2026)
2.2 Global Stroke Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Stroke Diagnostics and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stroke Diagnostics and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Stroke Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Stroke Diagnostics and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Stroke Diagnostics and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Stroke Diagnostics and Therapeutics Players by Market Size
3.1.1 Global Top Stroke Diagnostics and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Stroke Diagnostics and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Stroke Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Stroke Diagnostics and Therapeutics Market Concentration Ratio
3.2.1 Global Stroke Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Stroke Diagnostics and Therapeutics Revenue in 2019
3.3 Stroke Diagnostics and Therapeutics Key Players Head office and Area Served
3.4 Key Players Stroke Diagnostics and Therapeutics Product Solution and Service
3.5 Date of Enter into Stroke Diagnostics and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Stroke Diagnostics and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
5.2 Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Stroke Diagnostics and Therapeutics Market Size (2015-2020)
6.2 Stroke Diagnostics and Therapeutics Key Players in North America (2019-2020)
6.3 North America Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
6.4 North America Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Stroke Diagnostics and Therapeutics Market Size (2015-2020)
7.2 Stroke Diagnostics and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Stroke Diagnostics and Therapeutics Market Size (2015-2020)
8.2 Stroke Diagnostics and Therapeutics Key Players in China (2019-2020)
8.3 China Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
8.4 China Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Stroke Diagnostics and Therapeutics Market Size (2015-2020)
9.2 Stroke Diagnostics and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Stroke Diagnostics and Therapeutics Market Size (2015-2020)
10.2 Stroke Diagnostics and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Stroke Diagnostics and Therapeutics Market Size (2015-2020)
11.2 Stroke Diagnostics and Therapeutics Key Players in India (2019-2020)
11.3 India Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
11.4 India Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Stroke Diagnostics and Therapeutics Market Size (2015-2020)
12.2 Stroke Diagnostics and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Stroke Diagnostics and Therapeutics Introduction
13.1.4 Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Cordis
13.2.1 Cordis Company Details
13.2.2 Cordis Business Overview
13.2.3 Cordis Stroke Diagnostics and Therapeutics Introduction
13.2.4 Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.2.5 Cordis Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview
13.3.3 Boston Scientific Stroke Diagnostics and Therapeutics Introduction
13.3.4 Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 Siemens
13.4.1 Siemens Company Details
13.4.2 Siemens Business Overview
13.4.3 Siemens Stroke Diagnostics and Therapeutics Introduction
13.4.4 Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.4.5 Siemens Recent Development
13.5 Genentech
13.5.1 Genentech Company Details
13.5.2 Genentech Business Overview
13.5.3 Genentech Stroke Diagnostics and Therapeutics Introduction
13.5.4 Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.5.5 Genentech Recent Development
13.6 Koninklijke Philips
13.6.1 Koninklijke Philips Company Details
13.6.2 Koninklijke Philips Business Overview
13.6.3 Koninklijke Philips Stroke Diagnostics and Therapeutics Introduction
13.6.4 Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.6.5 Koninklijke Philips Recent Development
13.7 Medtronic
13.7.1 Medtronic Company Details
13.7.2 Medtronic Business Overview
13.7.3 Medtronic Stroke Diagnostics and Therapeutics Introduction
13.7.4 Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.7.5 Medtronic Recent Development
13.8 GE Healthcare
13.8.1 GE Healthcare Company Details
13.8.2 GE Healthcare Business Overview
13.8.3 GE Healthcare Stroke Diagnostics and Therapeutics Introduction
13.8.4 GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.8.5 GE Healthcare Recent Development
13.9 Stryker
13.9.1 Stryker Company Details
13.9.2 Stryker Business Overview
13.9.3 Stryker Stroke Diagnostics and Therapeutics Introduction
13.9.4 Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.9.5 Stryker Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview
13.10.3 Merck Stroke Diagnostics and Therapeutics Introduction
13.10.4 Merck Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020)
13.10.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Stroke Diagnostics and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Stroke Diagnostics and Therapeutics Revenue
Table 3. Ranking of Global Top Stroke Diagnostics and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Stroke Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostics
Table 6. Key Players of Therapeutics
Table 7. Global Stroke Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Stroke Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Stroke Diagnostics and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Stroke Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Stroke Diagnostics and Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Stroke Diagnostics and Therapeutics Players
Table 18. Global Stroke Diagnostics and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Stroke Diagnostics and Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Stroke Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stroke Diagnostics and Therapeutics as of 2019)
Table 21. Global Stroke Diagnostics and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Stroke Diagnostics and Therapeutics Product Solution and Service
Table 24. Date of Enter into Stroke Diagnostics and Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Stroke Diagnostics and Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Stroke Diagnostics and Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Stroke Diagnostics and Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Stroke Diagnostics and Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 34. North America Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 36. North America Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 40. Europe Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 46. China Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 48. China Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 52. Japan Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 64. India Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 66. India Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Stroke Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Stroke Diagnostics and Therapeutics Market Share (2019-2020)
Table 70. Central & South America Stroke Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Stroke Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Stroke Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Stroke Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Cordis Company Details
Table 80. Cordis Business Overview
Table 81. Cordis Product
Table 82. Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 83. Cordis Recent Development
Table 84. Boston Scientific Company Details
Table 85. Boston Scientific Business Overview
Table 86. Boston Scientific Product
Table 87. Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 88. Boston Scientific Recent Development
Table 89. Siemens Company Details
Table 90. Siemens Business Overview
Table 91. Siemens Product
Table 92. Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 93. Siemens Recent Development
Table 94. Genentech Company Details
Table 95. Genentech Business Overview
Table 96. Genentech Product
Table 97. Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 98. Genentech Recent Development
Table 99. Koninklijke Philips Company Details
Table 100. Koninklijke Philips Business Overview
Table 101. Koninklijke Philips Product
Table 102. Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 103. Koninklijke Philips Recent Development
Table 104. Medtronic Company Details
Table 105. Medtronic Business Overview
Table 106. Medtronic Product
Table 107. Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 108. Medtronic Recent Development
Table 109. GE Healthcare Business Overview
Table 110. GE Healthcare Product
Table 111. GE Healthcare Company Details
Table 112. GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 113. GE Healthcare Recent Development
Table 114. Stryker Company Details
Table 115. Stryker Business Overview
Table 116. Stryker Product
Table 117. Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 118. Stryker Recent Development
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Product
Table 122. Merck Revenue in Stroke Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 123. Merck Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stroke Diagnostics and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Stroke Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Ischemic Stroke Case Studies
Figure 6. Haemorrhagic Stroke Case Studies
Figure 7. Stroke Diagnostics and Therapeutics Report Years Considered
Figure 8. Global Stroke Diagnostics and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Stroke Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Stroke Diagnostics and Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Stroke Diagnostics and Therapeutics Market Share by Players in 2019
Figure 13. Global Top Stroke Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stroke Diagnostics and Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Stroke Diagnostics and Therapeutics Revenue in 2019
Figure 15. North America Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Stroke Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…- 虚血性脳卒中予防治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ischemic Cerebral…
- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 脳卒中管理の世界市場（～2026年） Stroke is the condition that occurs when the clot is formed in the artery and the oxygen supply to the brain is cut off, brain cells get deprived of oxygen and starts to die. Stroke can be thrombotic or embolic. Thrombotic stroke occurs when a blood clot is formed in the arteries that supply blood t…
- 心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…